A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Clinical trial NCT05071300 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05071300
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-04
- Primary completion
- 2029-08-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.